Mark Strobeck - 20 May 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Role
President and CEO, Director
Signature
/s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck
Issuer symbol
RMTI
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 18:56:20 UTC
Previous filing
02 Apr 2025
Next filing
03 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Strobeck Mark President and CEO, Director C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD, WIXOM /s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck 21 May 2025 0001599219

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Award $0 +220,000 +176% $0.000000 344,678 20 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMTI Stock Option (Right to Buy) Award $0 +308,000 $0.000000 308,000 20 May 2025 Common Stock 308,000 $1.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units vest on May 20, 2027, subject to the Reporting Person's continued service to the Issuer.
F2 Stock options vest 1/3 on the first anniversary of May 20, 2025, with the remaining vesting in equal monthly installments through May 20, 2028, subject to the Reporting Person's continued service to the Issuer.